Early-Onset Alzheimer Disease Clinical Trials in Indianapolis, Indiana
2 recruitingIndianapolis, Indiana
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Early-Onset Alzheimer Disease
Alnylam Pharmaceuticals60 enrolled8 locationsNCT05231785
Recruiting
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early-Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
Indiana University850 enrolled23 locationsNCT03507257